Domain > prove-api-eu.genesisresearch.io

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2022-06-15	52.28.8.61 (ClassC)
2024-09-08	3.121.146.253 (ClassC)
2024-10-25	52.29.79.171 (ClassC)
2025-01-01	3.77.243.234 (ClassC)
2025-05-04	3.69.82.201 (ClassC)
2025-05-23	3.72.226.106 (ClassC)
2025-06-02	3.124.121.11 (ClassC)

HTTP/1.1 200 OKDate: Sun, 08 Sep 2024 13:37:11 GMTContent-Type: text/html; charsetutf-8Content-Length: 3764Connection: keep-aliveServer: gunicornX-Frame-Options: DENYVary: originExpires: Sun, 08 Sep 2

!doctype html>html langen>head>    meta charsetutf-8>    meta nameviewport contentwidthdevice-width, initial-scale1>    meta namedescription content>    meta nameauthor contentGenesis Research, LLC>    title>Genesis Research: API Landing Page for SHI123/title>    link hrefhttps://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css relstylesheet          integritysha384-9ndCyUaIbzAi2FUVXJi0CjmCapSmO7SnpJef0486qhLnuZ2cdeRhO02iuK6FUUVM crossoriginanonymous>/head>body>div classcontainer>    main>        img classmx-auto d-block             srchttps://genesisrg.com/static/media/new_logo_for_website_2022.4a6077d4.png             altGenesis Research>        h1>About Genesis Research/h1>        p>            Genesis Research is an international real world evidence (RWE) and health economics and outcomes research            (HEOR) organization that delivers scientifically rigorous, tech-enabled solutions to pharmaceutical,            biotech, and medical device clients across the product lifecycle.        /p>        p>            An established leader in designing integrated evidence strategies, our RWE and HEOR partnerships include            literature synthesis, study design planning, data analysis, and scientific communications. Our research            findings are then optimally communicated to clients, as well as to regulatory, HTA/payer, and other            healthcare decision-makers, in alignment with client objectives.        /p>        p>            With our expertise in developing innovative, fit-for-purpose technological solutions, our clients benefit            from access to customized evidence management tools and dashboards that transform data into evidence; plus a            unique AI-powered literature review platform, EVID AI that employs machine learning to extract targeted data            from medical literature.        /p>        p>            In May 2022, Genesis Research acquired Market Access Transformation (MAT), an organization specializing in            developing agile technology

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > prove-api-eu.genesisresearch.io

Is this malicious?

DNS Resolutions

Port 443